Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Lancet ; 397(10279): 1085-1094, 2021 03 20.
Artículo en Inglés | MEDLINE | ID: mdl-33711294

RESUMEN

BACKGROUND: In cardiovascular disease, prevention strategies targeting standard modifiable cardiovascular risk factors (SMuRFs; hypertension, diabetes, hypercholesterolaemia, and smoking) are crucial; however, myocardial infarction in the absence of SMuRFs is not infrequent. The outcomes of individuals without SMuRFs are not well known. METHODS: We retrospectively analysed adult patients with first-presentation ST-elevation myocardial infarction (STEMI) using data from the Swedish myocardial infarction registry SWEDEHEART. Clinical characteristics and outcomes of adult patients (age ≥18 years) with and without SMuRFs were examined overall and by sex. Patients with a known history of coronary artery disease were excluded. The primary outcome was all-cause mortality at 30 days after STEMI presentation. Secondary outcomes included cardiovascular mortality, heart failure, and myocardial infarction at30 days. Endpoints were also examined up to discharge, and to the end of a 12-year follow-up. Multivariable logistic regression models were used to compare in-hospital mortality, and Cox-proportional hazard models and Kaplan-Meier analysis for long-term outcomes. FINDINGS: Between Jan 1, 2005, and May 25, 2018, 9228 (14·9%) of 62 048 patients with STEMI had no SMuRFs reaching diagnostic thresholds. Median age was similar between patients with SMuRFs and patients without SMuRFs (68 years [IQR 59-78]) vs 69 years [60-78], p<0·0001). SMuRF-less patients had a similar rate of percutaneous coronary intervention to those with at least one modifiable risk factor, but were significantly less likely to receive statins, angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockade (ARB), or ß-blockers at discharge. By 30 days after presentation, all-cause mortality was significantly higher in SMuRF-less patients (hazard ratio 1·47 [95% CI 1·37-1·57], p<0·0001). SMuRF-less women had the highest 30-day mortality (381 [17·6%] of 2164), followed by women with SMuRFs (2032 [11·1%] of 18 220), SMuRF-less men (660 [9·3%] of 7064), and men with SMuRFs (2117 [6·1%] of 34 600). The increased risk of 30-day all-cause mortality in SMuRF-less patients remained significant after adjusting for age, sex, left ventricular ejection fraction, creatinine, and blood pressure, but was attenuated on inclusion of pharmacotherapy prescription (ACEI or ARB, ß-blocker, or statin) at discharge. Additionally, SMuRF-less patients had a significantly higher rate of in-hospital all-cause mortality than patients with one or more SMuRF (883 [9·6%] vs 3411 [6·5%], p<0·0001). Myocardial infarction and heart failure at 30 days were lower in SMuRF-less patients. All-cause mortality remained increased in the SMuRF-less group for more than 8 years in men and up to the 12-year endpoint in women. INTERPRETATION: Individuals who present with STEMI in the absence of SMuRFs have a significantly increased risk of all-cause mortality, compared with those with at least one SMuRF, which was particularly evident in women. The increased early mortality rates are attenuated after adjustment for use of guideline-indicated treatments, highlighting the need for evidence-based pharmacotherapy during the immediate post-infarct period irrespective of perceived low risk. FUNDING: Swedish Heart and Lung Foundation, National Health and Medical Research Council (Australia).


Asunto(s)
Quimioterapia/normas , Insuficiencia Cardíaca/mortalidad , Mortalidad Hospitalaria/tendencias , Infarto del Miocardio/mortalidad , Intervención Coronaria Percutánea/estadística & datos numéricos , Infarto del Miocardio con Elevación del ST/mortalidad , Antagonistas Adrenérgicos beta/uso terapéutico , Anciano , Antagonistas de Receptores de Angiotensina/uso terapéutico , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Diabetes Mellitus/tratamiento farmacológico , Diabetes Mellitus/prevención & control , Quimioterapia/métodos , Femenino , Factores de Riesgo de Enfermedad Cardiaca , Insuficiencia Cardíaca/epidemiología , Insuficiencia Cardíaca/fisiopatología , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Hipercolesterolemia , Hipertensión/tratamiento farmacológico , Hipertensión/prevención & control , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/epidemiología , Infarto del Miocardio/etiología , Evaluación de Resultado en la Atención de Salud , Sistema de Registros , Estudios Retrospectivos , Infarto del Miocardio con Elevación del ST/diagnóstico , Infarto del Miocardio con Elevación del ST/fisiopatología , Prevención del Hábito de Fumar/normas , Suecia/epidemiología
2.
Adv Exp Med Biol ; 1262: 59-94, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32613580

RESUMEN

Smoking is a harmful habit, causing a range of severe consequences which could lead to premature death. This habit is still prevalent amongst young people. In order to protect children, effective early interventions supported by public instances need to be set in place. Raising awareness and educating the youth is crucial to change their mindset about the severity of smoking. Emerging technologies, such as augmented reality (AR) on mobile devices, have been shown to be useful in providing engaging experiences and educating children about a range of issues, including health and anatomy. This chapter presents a research which explores the use of AR as an exciting and engaging medium to effectively help educating children from 5 to 13 years about the effects of smoking. A mobile application, called SmokAR, was developed. This app includes AR visualization amongst other functionalities, whereby children are presented a realistic model of the human lungs of a healthy person and of a smoker. The aim of this research is to propose a transformative experience in order to put children off this dangerous habit whilst they gain knowledge about the effect of smoking on their organs. The anatomical accuracy of the 3D models and animations proposed by the app has been verified by an expert anatomist. A group of children (n = 17) also took part in usability and knowledge acquisition testing at the Glasgow Science Centre. Findings showed a significant high usability suggesting a user-friendly app design. Moreover, results also suggested that participants gained knowledge to a certain extent and felt discouraged from smoking after seeing the model of the smoker's lungs. Although there were several limitations to the study, the potential of the app to support learning and raising awareness is encouragingly positive. In addition, user testing in a more controlled environment, such as a classroom, can help gain further insights into the effectiveness and usability of the app. In the future, this simple but engaging approach to raise public awareness and support education could be used to further communicate with children about negative health effects of other harmful habits such as alcohol or drug consumption.


Asunto(s)
Realidad Aumentada , Vestuario , Aplicaciones Móviles , Prevención del Hábito de Fumar , Adolescente , Niño , Preescolar , Humanos , Aprendizaje , Aplicaciones Móviles/normas , Prevención del Hábito de Fumar/métodos , Prevención del Hábito de Fumar/normas
5.
BMC Pregnancy Childbirth ; 20(1): 31, 2020 Jan 13.
Artículo en Inglés | MEDLINE | ID: mdl-31931742

RESUMEN

BACKGROUND: Evidence suggests that cigarette smoking and alcohol consumption during pregnancy negatively impacts fetal health. Health agencies across countries have developed specific guidelines for health professionals in perinatal care to strengthen their role in smoking and alcohol use prevention. One such example is the "Guideline on Screening and Counselling for prevention of cigarette smoking and alcohol consumption before, during, and after pregnancy" introduced by the Swiss Midwives Association in 2011. The current study assesses the changes in midwives' engagement in smoking and alcohol use prevention before (2008) and after the introduction of the Guideline (2018). Further, the current study examines differences across regions (German vs. French speaking regions), graduation years (before and after the introduction of the Guideline) and different work settings (hospital vs. self-employed). METHODS: Survey data were collected in 2008 (n = 366) and in 2018 (n = 459). Differences in how midwives engaged in smoking and alcohol use prevention between 2008 and 2018 were assessed with chi-square tests, as were differences across German and French speaking regions, graduation years (before and after the introduction of the Guideline) and across different work settings (working in hospitals or as self-employed). RESULTS: An increase in midwives' awareness of the risks of consuming even small quantities of cigarettes and alcohol for the unborn child between 2008 and 2018 is evident. Explaining the risks to pregnant women who smoke or use alcohol remained the most frequently reported prevention strategy. However, engagement with more extensive smoking and alcohol use preventive strategies across the whole course of pregnancy, such as assisting women in the elaboration of a plan to stop smoking/alcohol use, remained limited. CONCLUSIONS: Seven years after its introduction, the effectiveness of the Guideline in increasing midwives' engagement in smoking and alcohol use prevention appears limited despite midwives' increased awareness.


Asunto(s)
Consumo de Bebidas Alcohólicas/prevención & control , Partería/estadística & datos numéricos , Atención Prenatal/estadística & datos numéricos , Prevención del Hábito de Fumar/estadística & datos numéricos , Participación de los Interesados/psicología , Adulto , Femenino , Conocimientos, Actitudes y Práctica en Salud , Implementación de Plan de Salud , Humanos , Partería/normas , Guías de Práctica Clínica como Asunto , Embarazo , Atención Prenatal/métodos , Atención Prenatal/normas , Prevención del Hábito de Fumar/métodos , Prevención del Hábito de Fumar/normas , Encuestas y Cuestionarios , Suiza
6.
Health Educ Res ; 35(1): 32-43, 2020 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-31943060

RESUMEN

School tobacco policies (STPs) are a crucial strategy to reduce adolescents smoking. Existing studies have investigated STPs predominantly from a school-related 'insider' view. Yet, little is known about barriers that are not identified from the 'schools' perspective', such as perceptions of local stakeholders. Forty-six expert interviews from seven European cities with stakeholders at the local level (e.g. representatives of regional health departments, youth protection and the field of addiction prevention) were included. The analysis of the expert interviews revealed different barriers that should be considered during the implementation of STPs. These barriers can be subsumed under the following: (i) Barriers regarding STP legislature (e.g. inconsistencies, partial bans), (ii) collaboration and cooperation problems between institutions and schools, (iii) low priority of smoking prevention and school smoking bans, (iv) insufficient human resources and (v) resistance among smoking students and students from disadvantaged backgrounds. Our findings on the expert's perspective indicate a need to enhance and implement comprehensive school smoking bans. Furthermore, collaboration and cooperation between schools and external institutions should be fostered and strengthened, and adequate human resources should be provided.


Asunto(s)
Instituciones Académicas/normas , Política para Fumadores/tendencias , Prevención del Hábito de Fumar/organización & administración , Fumar Tabaco/prevención & control , Adolescente , Ciudades , Relaciones Comunidad-Institución , Conducta Cooperativa , Europa (Continente) , Femenino , Humanos , Masculino , Investigación Cualitativa , Prevención del Hábito de Fumar/legislación & jurisprudencia , Prevención del Hábito de Fumar/normas , Conducta Social , Factores Socioeconómicos
8.
Ann Oncol ; 30(8): 1356-1369, 2019 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-31147719

RESUMEN

BACKGROUND: Cancer mortality in Europe has been decreasing since the late 1980s or 1990s in some countries with different patterns in many areas. In this study, we updated trends in cancer mortality in Europe. MATERIALS AND METHODS: We extracted data from the World Health Organization mortality database for 24 cancer sites, 36 European countries and the European Union (EU) as a whole over the 1990-2017 period. We computed age-standardized death rates per 100 000 person-years, and we carried out a joinpoint regression analysis of mortality trends from all cancers and selected major neoplasms. The estimated annual percent change (APC) for each identified linear segment, and the weighted average APC (AAPC) over the entire study period were provided as summary measures of the changes in rates over the time period. RESULTS: In 2015, the age-standardized mortality rates from all cancers in the EU were 137.5 deaths per 100 000 in men and 85.7 in women. Eastern European countries showed the highest rates with values over 150 deaths per 100 000 in men and over 100 deaths per 100 000 in women. Mortality from all cancers in the EU declined annually by 1.5% in men since 2006 and by 0.8% in women since 2007. Most cancer sites showed decreasing trends, with steady declines over the whole period for cancers of stomach, intestines, lung in men, breast and prostate. Unfavourable mortality trends persisted for cancers of liver, lung in women, pancreas, besides skin and kidney in men. CONCLUSIONS: The downward trends in total cancer mortality in Europe still continue over the last decade. However, the trends were less favourable in most eastern European countries. Tobacco control in men (but not in women), improvements in diagnosis and therapy were the main underlying factors of these trends.


Asunto(s)
Mortalidad/tendencias , Neoplasias/mortalidad , Adolescente , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Bases de Datos Factuales/estadística & datos numéricos , Europa (Continente)/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Política Pública , Factores Sexuales , Prevención del Hábito de Fumar/normas , Fumar Tabaco/efectos adversos , Fumar Tabaco/epidemiología , Fumar Tabaco/prevención & control , Organización Mundial de la Salud , Adulto Joven
9.
Lancet Oncol ; 20(4): e208-e217, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30942182

RESUMEN

Smokeless tobacco is consumed by 356 million people globally and is a leading cause of head and neck cancers. However, global efforts to control smokeless tobacco use trail behind the progress made in curbing cigarette consumption. In this Policy Review, we describe the extent of the policy implementation gap in smokeless tobacco control, discuss key reasons on why it exists, and make recommendations on how to bridge this gap. Although 180 countries have agreed that the WHO Framework Convention on Tobacco Control is the best approach to control the demand and supply of smokeless tobacco, only 138 (77%) Parties define smokeless tobacco in their statutes. Only 34 (19%) Parties tax or report taxing smokeless tobacco products, six (3%) measure content and emissions of smokeless tobacco products, and 41 (23%) mandate pictorial health warnings on these products. Although awareness of the harms related to smokeless tobacco is growing in many parts of the world, few Parties collect or present data on smokeless tobacco use under global or national surveillance mechanisms (eg, Global Tobacco Surveillance System and WHO STEPwise). Only 16 (9%) Parties have implemented a comprehensive ban on smokeless tobacco advertisement, promotion, and sponsorships. Globally, a smaller proportion of smokeless tobacco users are advised to quit the use of smokeless tobacco products compared to tobacco users. Use of smokeless tobacco is becoming a global cause of concern, requiring a greater commitment on the full implementation of the WHO Framework Convention on Tobacco Control measures.


Asunto(s)
Política de Salud/legislación & jurisprudencia , Prevención del Hábito de Fumar/legislación & jurisprudencia , Tabaco sin Humo/legislación & jurisprudencia , Humanos , Cooperación Internacional , Fumar/efectos adversos , Fumar/epidemiología , Prevención del Hábito de Fumar/normas , Prevención del Hábito de Fumar/estadística & datos numéricos , Control Social Formal , Tabaco sin Humo/efectos adversos , Organización Mundial de la Salud
10.
Rev Epidemiol Sante Publique ; 67(3): 181-187, 2019 May.
Artículo en Francés | MEDLINE | ID: mdl-30954324

RESUMEN

BACKGROUND: Prohibition of tobacco sales to minors is a provision of the World Health Organization Framework Convention on tobacco control. This measure is effective to reduce youth tobacco use, if the legislation adopted is properly implemented and enforced. Through the examples of France and Quebec, the objective of this study is to compare legislative frameworks prohibiting tobacco sales to minors, their enforcement, and possible impact on underage smoking. METHODS: Identification of legislative instruments, reports from public health authorities, and articles addressing the focused question was performed trough Medline and Google. RESULTS: Selling tobacco products to minors under 18 years of age has been banned by the law since 1998 in Quebec and 2009 in France. In 2011, in France for individuals aged 17, compliance with the law was 15%. In 2017 in France, 94% of 17-year-old daily smokers regularly bought their cigarettes in a tobacco store. Law enforcement controls and sanctions are non-existent. In 2013 in Quebec, 23% of underage smoking students usually bought their own cigarettes in a business. The compliance rate with the prohibition law rose from 37% in 2003 to 92.6% in 2017. An approach of underage "mystery shoppers" attempting to purchase tobacco products and dedicated inspectors has been implemented, and progressive sanctions are applied in case of non-compliance. In 2013, 12.2% of Quebec high school students and, in 2017, 34.1% of French 17 year olds reported using tobacco products in the last 30 days. CONCLUSION: Only an improved law enforcement, through the training of tobacco retailer's, inspections and effective deterrent penalties for non-compliance, leads to an effective legislative measure in terms of public health.


Asunto(s)
Comercio/legislación & jurisprudencia , Aplicación de la Ley , Menores/legislación & jurisprudencia , Salud Pública/legislación & jurisprudencia , Prevención del Hábito de Fumar , Productos de Tabaco/legislación & jurisprudencia , Adolescente , Conducta del Adolescente , Niño , Comercio/estadística & datos numéricos , Francia/epidemiología , Humanos , Aplicación de la Ley/métodos , Legislación Médica , Menores/estadística & datos numéricos , Política Pública , Quebec/epidemiología , Fumar/epidemiología , Fumar/legislación & jurisprudencia , Prevención del Hábito de Fumar/legislación & jurisprudencia , Prevención del Hábito de Fumar/organización & administración , Prevención del Hábito de Fumar/normas , Prevención del Hábito de Fumar/estadística & datos numéricos , Industria del Tabaco/economía , Industria del Tabaco/legislación & jurisprudencia , Productos de Tabaco/economía , Tabaquismo/economía , Tabaquismo/epidemiología
11.
Nicotine Tob Res ; 21(12): 1652-1659, 2019 11 19.
Artículo en Inglés | MEDLINE | ID: mdl-30629264

RESUMEN

BACKGROUND: The World Health Organization's Framework Convention on Tobacco Control (FCTC) is the first international health treaty and has now been ratified by 181 countries. However, there are concerns that in many countries, particularly in sub-Saharan African countries, FCTC legislations and implementation are weak. In this study, we report a qualitative study undertaken to assess policy makers' awareness of the FCTC and national tobacco control policies, and assessed the achievements and challenges to the implementation of the FCTC in the Gambia. METHODS: The study involved semi-structured one-to-one interviews with 28 members of the National Tobacco Control Committee in the Gambia, which is responsible for formulating tobacco control policies and making recommendations for tobacco control. We used the Framework method and NVivo11 software for data analysis. RESULTS: Our findings demonstrate that the Gambia has made modest progress in tobacco control before and since ratification of the FCTC, particularly in the areas of policy formulation, bans on tobacco advertising and promotion, smoke-free laws, and tobacco taxation. Although several pieces of tobacco control legislation exist, enforcement and implementation remain a major challenge. We found that policy makers' awareness of polices covered in the FCTC was limited. CONCLUSION: Our findings highlight several challenges to the FCTC implementation and the need to step up efforts that will help to accomplish the obligations of the FCTC. To achieve the obligations of the FCTC, the Gambia should develop specific public awareness interventions, establish cessation services, mobilize adequate resources for tobacco control and strengthen tobacco surveillance and research.


Asunto(s)
Implementación de Plan de Salud/normas , Política de Salud/legislación & jurisprudencia , Prevención del Hábito de Fumar/normas , Productos de Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/prevención & control , Publicidad/estadística & datos numéricos , Gambia/epidemiología , Humanos , Cooperación Internacional/legislación & jurisprudencia , Investigación Cualitativa , Impuestos/legislación & jurisprudencia , Contaminación por Humo de Tabaco/legislación & jurisprudencia , Organización Mundial de la Salud
12.
Am J Health Behav ; 43(1): 88-104, 2019 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-30522569

RESUMEN

Objective: There is a lack of consensus on whether e-cigarettes facilitate or threaten existing tobacco prevention strategies. This uncertainty is reflected in organizations' conflicting e-cigarette position statements. We conducted a scoping review of position statements in published and gray literature to map the range and frequency of e-cigarette use recommendations. Methods: We collected 81 statements from international health organizations. Two coders independently performed qualitative content analysis to categorize e-cigarette recommendations. We explored differences based on organization type, geography, and the year recommendations were published. Results: We identified 5 recommendation types: encourage smokers to use ecigarettes as a cessation aid or as an alternative source of nicotine (N = 5); support individuals who use e-cigarettes to quit smoking (N = 20); avoid using until more research is available (N = 19); restrict access based on available evidence (N = 30); and prohibit e-cigarette marketing and sale (N = 7). Conclusion: Organizations presented diverse e-cigarette use recommendations. The variation related to organizations' differing tobacco prevention priorities and level of confidence in current e-cigarette research. These differences may create confusion. Additional research can examine whether this variability influences stakeholders' attitudes or behavior.


Asunto(s)
Sistemas Electrónicos de Liberación de Nicotina/normas , Guías como Asunto/normas , Cese del Hábito de Fumar , Prevención del Hábito de Fumar/normas , Vapeo , Humanos
13.
Nicotine Tob Res ; 21(7): 855-862, 2019 06 21.
Artículo en Inglés | MEDLINE | ID: mdl-29444268

RESUMEN

BACKGROUND: The World Health Organization's Framework Convention on Tobacco Control recommends prominent pictorial health warnings on tobacco products. To advance research methods, theory and understanding of how tobacco product warning labels (TPWLs) work, the US National Cancer Institute convened a grantee meeting. Our article describes the key insights that emerged from the meeting, situated within the context of the scientific literature. RESULTS & RECOMMENDATIONS: First, presentations confirmed that large, pictorial TPWLs motivate people to try to quit and encourage smoking cessation. Second, pictorial TPWLs increase attention, knowledge, negative affect, and thinking about the warning. Third, TPWL studies have primarily used brief-exposure laboratory studies and observational studies of sustained exposure through national policy implementation, with a few randomized trials involving several weeks of exposure-with generally consistent results found across study designs. Fourth, novel assessment methods include brain imaging, eye tracking and "best-worst" discrete choice experiments. To make TPWL even more effective, research is needed to confirm the mechanisms of their influence, their impact across vulnerable populations, and their effect on social media posts about tobacco products. Research is also needed on the effect of trial design choices, the predictive validity of new measurement approaches, and warning labels for non-cigarette tobacco products. IMPLICATIONS: To improve scientific understanding of TPWL effects, this grantee meeting summary describes emerging research methods, theory and study results. Directions for future research include examination of the mechanisms of how warning labels work across diverse tobacco products and across different populations and contexts.


Asunto(s)
Congresos como Asunto , National Cancer Institute (U.S.) , Etiquetado de Productos/métodos , Prevención del Hábito de Fumar/métodos , Productos de Tabaco , Organización Mundial de la Salud , Adolescente , Adulto , Congresos como Asunto/normas , Femenino , Humanos , Masculino , National Cancer Institute (U.S.)/normas , Etiquetado de Productos/normas , Fumar/epidemiología , Fumar/tendencias , Cese del Hábito de Fumar/métodos , Prevención del Hábito de Fumar/normas , Productos de Tabaco/normas , Estados Unidos/epidemiología , Poblaciones Vulnerables , Adulto Joven
14.
Tob Control ; 28(4): 381-385, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30104409

RESUMEN

AIMS: Exposure to audiovisual tobacco content in media is a risk factor for smoking in young people. While tobacco content in films has been extensively documented, content in mainstream television has received relatively little attention. We report an analysis of tobacco content in a sample of UK free-to-air prime-time television broadcasts in 2015, and compare this with a similar analysis from 2010. DESIGN: Content analysis of all programmes and advertisements or trailers broadcast on the five national UK free-to-air channels in the UK between 18:00 and 22:00 during three separate weeks in September, October and November 2015. SETTING: Great Britain. PARTICIPANTS: None (media analysis only). MEASUREMENTS: Occurrence of any tobacco, tobacco use, implied use, other tobacco reference/related objects and branding in every 1 min coding interval. FINDINGS: Tobacco content occurred in 33% of all programmes and 8% of all adverts or programme trailer breaks. Actual tobacco use occurred in 12% of all programmes broadcast. Tobacco-related objects, primarily no smoking signs, occurred in 2% of broadcasts; implied tobacco use and tobacco branding were also rare. The majority of tobacco content occurred after the 21:00 watershed. CONCLUSIONS: These findings are virtually unchanged from our earlier analysis of programme content from 2010. Audiovisual tobacco content remains common in UK television programmes.


Asunto(s)
Publicidad , Salud Pública/métodos , Medios de Comunicación Sociales , Televisión , Productos de Tabaco , Publicidad/ética , Publicidad/legislación & jurisprudencia , Publicidad/estadística & datos numéricos , Niño , Humanos , Acceso a Internet/estadística & datos numéricos , Evaluación de Necesidades , Factores de Riesgo , Prevención del Hábito de Fumar/normas , Medios de Comunicación Sociales/ética , Medios de Comunicación Sociales/normas , Medios de Comunicación Sociales/estadística & datos numéricos , Televisión/normas , Televisión/estadística & datos numéricos , Factores de Tiempo , Reino Unido , Adulto Joven
15.
Nicotine Tob Res ; 21(7): 863-870, 2019 06 21.
Artículo en Inglés | MEDLINE | ID: mdl-29370431

RESUMEN

INTRODUCTION: A range of tobacco control policies endeavor to prevent smoking uptake in young people, yet relatively little is known about how such interventions impact young people's engagement with smoking. We reviewed existing qualitative evidence on young people and smoking in Europe to assess whether, in what ways and why young people comply with, adapt to, resist, or circumvent tobacco control policies in their respective countries. METHODS: We undertook a systematic review of academic literature presenting qualitative research from Europe on smoking and young people (11-18 years), published from 2000 to 2015. Bibliographic searches (PubMed, PsycInfo, SSCI) produced 1357 records, from which 43 relevant articles were assessed for quality and 39 included in the review. RESULTS: Most studies were from the United Kingdom (27), with a small number (one or two each) from other European countries (Denmark, Sweden, Switzerland, Belgium, Cyprus, Greece, Hungary, Ireland, and Spain). Only 16 articles (11 from United Kingdom) provided any evidence about the impacts of tobacco control policies on young people's smoking. These focused on smoke-free legislation (four), age of sale laws (four), plain packaging (three), and black market tobacco (one). CONCLUSIONS: There is very little qualitative evidence exploring the impacts of tobacco control on youth smoking in Europe. To develop more effective smoking prevention policies that take account of local political, social, and cultural contexts, more qualitative research from a wider range of European countries is needed to understand how tobacco control impacts on young people's social worlds and smoking behaviors. IMPLICATIONS: Smoking is the leading cause of premature mortality in Europe. However, there is little qualitative evidence exploring the impact of tobacco control policies on young people in Europe. Most comes from the United Kingdom and focuses on a narrow range of policies. Thus, we have a limited understanding of how and in what ways tobacco control policies reach young people, their engagement with these, and how local context affects their impact. More qualitative research is needed, from a wider range of countries and on a broader range of tobacco control policies, to strengthen the evidence-base for reducing youth smoking.


Asunto(s)
Política Pública , Investigación Cualitativa , Prevención del Hábito de Fumar/normas , Productos de Tabaco/normas , Adolescente , Niño , Comercio/métodos , Comercio/normas , Europa (Continente)/epidemiología , Femenino , Humanos , Masculino , Embalaje de Productos/métodos , Embalaje de Productos/normas , Prevención del Hábito de Fumar/métodos , Reducción del Consumo de Tabaco/métodos , Productos de Tabaco/efectos adversos
16.
Nicotine Tob Res ; 21(7): 879-886, 2019 06 21.
Artículo en Inglés | MEDLINE | ID: mdl-29917125

RESUMEN

OBJECTIVES: Recent research has shown that message congruency is beneficial to recall of pictorial health warning label (PWL) content after initial exposure. Despite less attention to the text warning, smokers exposed to congruent PWLs were more likely to recall the text and the message. This study aimed to replicate these findings and to examine whether congruency also affects recall after multiple exposures over time. METHODS: A total of 320 daily smokers (39.7% female; cigarettes/day: M = 15.31, SD = 7.15) were randomized to one congruent or incongruent PWL and attended 4 laboratory sessions over 10 days. During each session, eye movements were recorded while viewing the PWL and open-ended recall of label content was assessed after exposure. RESULTS: Smokers who were exposed to a congruent PWL were more likely to recall the text (p = .01) and the message (p = .02) and less likely to recall the image (p = .003) of the PWL after initial exposure. By day 4, incongruent PWLs were recalled equally well as congruent PWLs. Independent of condition, image recall was initially high and remained high whereas text and message recall was relatively low initially but increased over time. It was not until day 7 that about 80% of text and message recall was observed. CONCLUSIONS: Even when exposed to the same PWL over time, smokers require multiple exposures to recall the text and the message of a PWL. More research on the effects of congruency in the natural environment, where smokers are exposed to multiple PWLs, is needed. IMPLICATIONS: The findings of this study, and of previous work showing that message congruency in PWLs is beneficial to initial recall of PWL content, could potentially help to address legal challenges regarding the implementation of PWLs in the United States. Factually correct text warnings have been uncontested on US cigarettes packages since 1966. Congruent PWLs simply provide a means to visually support the same information as the existing text using a medium that better garners attention to the health information. Investigating and understanding longer-term effects of congruency are important and can empirically inform future warning label development, both in the United States via the Family Smoking Prevention and Tobacco Control Act, and via other governing bodies.


Asunto(s)
Atención/fisiología , Recuerdo Mental/fisiología , Etiquetado de Productos/métodos , Fumadores/psicología , Prevención del Hábito de Fumar/métodos , Productos de Tabaco/efectos adversos , Adulto , Anciano , Movimientos Oculares/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Etiquetado de Productos/normas , Prevención del Hábito de Fumar/normas , Factores de Tiempo , Estados Unidos , Adulto Joven
18.
Eur J Public Health ; 28(4): 693-701, 2018 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-29554253

RESUMEN

Background: While some WHO European Region countries are global tobacco control leaders, the South Eastern region of Europe has the highest tobacco smoking prevalence globally and a relatively low level of overall implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC). An abridged version of SimSmoke has been developed to project the health impact of implementing tobacco control policies in line with the WHO FCTC. Methods: Data on population size, smoking prevalence, policy-specific effect sizes and formulas were applied in 11 South Eastern WHO European Region countries [Albania, Bosnia and Herzegovina (the Federation of Bosnia and Herzegovina and the Republika Srpska), Bulgaria, Croatia, Israel, Montenegro, Republic of Moldova, Romania, Serbia, Slovenia and the former Yugoslav Republic of Macedonia] to project the relative reduction in smoking prevalence, number of smokers and number of smoking-attributable deaths resulting from implementing individual and/or combined six WHO FCTC measures. Results: For all countries, an increase in excise cigarette taxes to 75% of price yields the largest relative reduction in smoking prevalence (range 8-28%). The projections show that within 15 years smoking prevalence can be reduced by at least 30% in all countries when all six tobacco control measures are fully implemented in line with the WHO FCTC. Conclusion: The projections show that large health effects can be achieved and the results can be used as an advocacy tool towards acceleration of the enforcement of tobacco control laws in WHO European Region countries.


Asunto(s)
Causas de Muerte , Política de Salud , Prevención del Hábito de Fumar/legislación & jurisprudencia , Prevención del Hábito de Fumar/normas , Fumar/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Albania/epidemiología , Bosnia y Herzegovina/epidemiología , Bulgaria/epidemiología , Croacia/epidemiología , Femenino , Humanos , Israel/epidemiología , Masculino , Persona de Mediana Edad , Moldavia/epidemiología , Montenegro/epidemiología , Prevalencia , Rumanía/epidemiología , Serbia/epidemiología , Eslovenia/epidemiología , Fumar/epidemiología
19.
Transl Behav Med ; 8(5): 692-695, 2018 09 08.
Artículo en Inglés | MEDLINE | ID: mdl-29385561

RESUMEN

The Society of Behavioral Medicine supports the inclusion of gender and sexual minorities in all local, state, and national tobacco prevention and control activities. These activities include surveillance of tobacco use and cessation activities, targeted outreach and awareness campaigns, increasing access to culturally appropriate tobacco use dependence treatments, and restricting disproportionate marketing to lesbian, gay, bisexual, and transgender communities by the tobacco industry, especially for mentholated tobacco products.


Asunto(s)
Medicina de la Conducta , Educación en Salud , Minorías Sexuales y de Género , Cese del Hábito de Fumar , Sociedades Médicas , Tabaquismo/terapia , Medicina de la Conducta/legislación & jurisprudencia , Medicina de la Conducta/normas , Educación en Salud/legislación & jurisprudencia , Educación en Salud/normas , Promoción de la Salud/legislación & jurisprudencia , Promoción de la Salud/normas , Humanos , Minorías Sexuales y de Género/legislación & jurisprudencia , Prevención del Hábito de Fumar/legislación & jurisprudencia , Prevención del Hábito de Fumar/normas , Sociedades Médicas/legislación & jurisprudencia , Sociedades Médicas/normas
20.
Cad Saude Publica ; 33Suppl 3(Suppl 3): e00168315, 2017 Oct 19.
Artículo en Portugués, Inglés | MEDLINE | ID: mdl-29069213

RESUMEN

This research examines the institutional features of Brazil's National Commission for the Implementation of the Framework Convention on Tobacco Control (CONICQ) and how these institutional features have facilitated and hindered its ability to foster intersectoral tobacco control. In particular, we evaluate the key institutional features of CONICQ starting from when it was one of the key drivers of change and improvements in early tobacco control policies, which helped to make Brazil a world leader in this area. We also examine how the committee has evolved, as tobacco control has improved and particularly elucidate some of the major challenges that it faces to bring together often disparate government sectors to generate public health policies.


Resumo: Esta pesquisa examina as características institucionais da Comissão Nacional para a Implementação da Convenção-Quadro sobre Controle do Tabaco (CONICQ) e como essas características institucionais facilitaram e impediram sua capacidade de promover o controle intersetorial do tabagismo. Os autores avaliam particularmente as características da CONICQ enquanto um dos principais fatores de mudanças e melhorias nas primeiras políticas de controle do tabaco, e que ajudaram a transformar o Brasil em líder mundial nessa área. O artigo também analisa como a Comissão evoluiu junto com a melhora do controle do tabaco, além de discutir alguns dos maiores desafios para reunir diversos setores do governo na elaboração de políticas de saúde pública.


Resumen: Esta investigación examina las características institucionales de la Comisión Nacional para la Implementación del Convenio Marco para el Control del Tabaco (CONICQ) y cómo estas características institucionales han facilitado y dificultado su capacidad de fomentar el control intersectorial del tabaco en Brasil. En particular, evaluamos las características clave institucionales de la CONICQ, cuando era uno de los agentes clave de cambios y mejoras en las primeras políticas de control de tabaco, que ayudaron a hacer de Brasil un líder mundial en esta área. También examinamos cómo el comité ha evolucionado al mejorar el control del tabaco y, particularmente, elucidar algunos de los mayores desafíos a los que se enfrenta para aunar sectores gubernamentales a menudo dispares, con el fin de generar políticas de públicas de salud.


Asunto(s)
Política de Salud , Prevención del Hábito de Fumar/organización & administración , Prevención del Hábito de Fumar/normas , Tabaquismo/prevención & control , Brasil , Política de Salud/legislación & jurisprudencia , Humanos , Comité de Profesionales , Industria del Tabaco/legislación & jurisprudencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...